Effects of a Therapeutic Interchange Between Branded and Generic Inhaled Therapy on Chronic Obstructive Pulmonary Disease

Authors

Rucha B Acharya, Nova Southeastern UniversityFollow
Tina Joseph, Nova Southeastern UniversityFollow
Cynthia Moreau, Nova Southeastern UniversityFollow
Genevieve M. Hale, Nova Southeastern UniversityFollow
Alexandra Perez, Nova Southeastern UniversityFollow
Elaina Rosario, Nova Southeastern UniversityFollow

Publication Title

The Senior Care Pharmacist

Publisher

American Society of Consultant Pharmacists (ASCP)

ISSN

2639-9636

Publication Date

12-2021

Keywords

adrenergic beta-2 receptor agonists, bronchodilator agents, humans, nebulizers and vaporizers, pulmonary disease, chronic obstructive, retrospective studies

DOI

10.4140/tcp.n.2021.687

Volume

36

Issue

12

First Page

687

Last Page

692

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

NSUWorks Citation

Acharya, Rucha B; Joseph, Tina; Moreau, Cynthia; Hale, Genevieve M.; Perez, Alexandra; and Rosario, Elaina, "Effects of a Therapeutic Interchange Between Branded and Generic Inhaled Therapy on Chronic Obstructive Pulmonary Disease" (2021). Faculty Articles. 391.
https://nsuworks.nova.edu/hpd_corx_facarticles/391